Final Panel Thoughts on Uncomplicated UTI Management

Panelists discuss how the management of uncomplicated urinary tract infections (UTIs) is evolving, with promising new therapies that address antibiotic resistance concerns, while emphasizing the continued importance of antimicrobial stewardship, personalized treatment approaches, preventive strategies, and comprehensive patient education to reduce recurrence rates and improve outcomes in this common but burdensome condition.

EP: 1.Differentiating Uncomplicated and Complicated Urinary Tract Infections (UTIs)

EP: 2.Trends in Uncomplicated UTIs

EP: 3.Exploring Social Determinants of Health in Uncomplicated UTIs

EP: 4.Examining Uncomplicated UTI Recurrence

EP: 5.Role of Patients’ Education in Uncomplicated UTIs

EP: 6.Patient Burden Associated With Uncomplicated UTIs

EP: 7.Minimizing Antibiotic Resistance Development in Uncomplicated UTIs

EP: 8.Examining the Need for Updated Guidelines for Uncomplicated UTIs

EP: 9.Comparing Standard-of-Care Antibiotics for Uncomplicated UTIs

EP: 10.Patient Factors Influencing Antibiotic Selection in Uncomplicated UTIs

EP: 11.Recurrence Rates in Uncomplicated UTIs

EP: 12.Economic Burden Associated With Uncomplicated UTIs

EP: 13.Important Updates in the Management of Uncomplicated UTIs

EP: 14.Exploring Novel Options for the Management of Uncomplicated UTIs

EP: 15.Comparing Newer With Traditional Agents in Uncomplicated UTIs

EP: 16.Payer-Related Barriers With Therapies Used for Uncomplicated UTIs

Now Viewing

EP: 17.Final Panel Thoughts on Uncomplicated UTI Management

Related Videos

Related Content

Advertisement

May 2nd 2025

Expanding Resources, Clinical Knowledge to Enhance AYA NHL Care: Andrew Evens, DO

Kyle Munz Andrew Evens, DO

To better treat adolescent and young adult (AYA) patients with various subtypes of Hodgkin and non-Hodgkin lymphomas (NHL), Andrew Evens, DO, speaks to the importance of primary care, screening access, and research.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

May 1st 2025

Short-Term Improvements Seen in Patients With nAMD Switching to Faricimab

Julia Bonavitacola

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and subretinal and intraretinal fluid after switching.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

April 28th 2025

PH, PAH Prevalence Higher in Medicaid, With Racial, Ethnic Disparities

Laura Joszt, MA

Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.

April 24th 2025

Science at AACR Aims to Overcome Cancer Care Barriers

Mary Caffrey Brooke McCormick

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for Cancer Research annual meeting runs April 25-30, with the key presentations coming Sunday through Tuesday.

Related Content

Advertisement

May 2nd 2025

Expanding Resources, Clinical Knowledge to Enhance AYA NHL Care: Andrew Evens, DO

Kyle Munz Andrew Evens, DO

To better treat adolescent and young adult (AYA) patients with various subtypes of Hodgkin and non-Hodgkin lymphomas (NHL), Andrew Evens, DO, speaks to the importance of primary care, screening access, and research.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

May 1st 2025

Short-Term Improvements Seen in Patients With nAMD Switching to Faricimab

Julia Bonavitacola

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and subretinal and intraretinal fluid after switching.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

April 28th 2025

PH, PAH Prevalence Higher in Medicaid, With Racial, Ethnic Disparities

Laura Joszt, MA

Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.

April 24th 2025

Science at AACR Aims to Overcome Cancer Care Barriers

Mary Caffrey Brooke McCormick

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for Cancer Research annual meeting runs April 25-30, with the key presentations coming Sunday through Tuesday.